Profil
Kirsten Harting currently works at SynAct Pharma AB, as Chief Medical Officer from 2024 and Tetra Pharm Technologies ApS, as Chief Medical Officer.
Dr. Harting also formerly worked at CytoKi Pharma ApS, as Senior Director-Medical, Alzinova AB, as Chief Medical Officer from 2023 to 2025, and Sandoz Group AG, as Chief Medical Officer.
Dr. Harting received her Masters Business Admin degree from Copenhagen Business School and doctorate degree from the University of Copenhagen.
Aktive Positionen von Kirsten Harting
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNACT PHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 15.02.2024 |
Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Engages in the design and development of new drug formulations, conduct clinical trials and commercialize medicines | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Kirsten Harting
| Unternehmen | Position | Ende |
|---|---|---|
| ALZINOVA AB | Technik-/Wissenschafts-/F&E-Leiter | 28.01.2025 |
| SANDOZ GROUP AG | Technik-/Wissenschafts-/F&E-Leiter | - |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kirsten Harting
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
SynAct Pharma AB
SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Engages in the design and development of new drug formulations, conduct clinical trials and commercialize medicines | Health Technology |
Sandoz Group AG
Sandoz Group AG Pharmaceuticals: MajorHealth Technology Manufactures medicines and biosimilars | Health Technology |
















